CommercialCoverageMedium impact
06.03.04p, Apheresis Therapy
Independence Blue Cross·Hematology, Oncology, Nephrology +1 more·Medical Policy
Effective date
Jun 8, 2026
We identified it
Jun 19, 2026
Summary
Medical necessity criteria for Apheresis Therapy procedures are being updated effective June 8, 2026. This policy change will modify the requirements for determining when apheresis treatments are considered medically necessary for commercial insurance plans.
Action Required
Before June 8, 2026: Clinical and billing teams must review updated medical necessity criteria for apheresis therapy procedures. Update internal documentation requirements and prior authorization processes to align with new criteria. Ensure providers understand revised medical necessity standards to prevent claim denials.